| Full Name | Ping Gu |
|---|---|
| Gender | Male |
| Speciality | Medical Oncology |
| Experience | 39 Years |
| Location | 225 Summit Avenue, Montvale, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336383637 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RX0202X | Internal Medicine - Medical Oncology | 250997 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Amedisys Home Health | Hackensack, NJ | Home health agency |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Msk Bergen | 1456614114 | 132 |
News Archive
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that its collaborator Genentech, a member of the Roche Group, has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking sales and marketing approval for vismodegib to treat people with advanced basal cell carcinoma (BCC), which includes metastatic and locally advanced BCC for whom surgery is inappropriate.
How do viral pathogens succeed in penetrating human cells? Which cellular mechanisms do they use to multiply efficiently and, in doing so, how do they change the structure of their host cell? These questions are the focus of a pan-European research project called "Compact Cell-Imaging Device" (CoCID), in which Heidelberg scientists are playing a major role.
In a new development, health insurer Blue Shield of California has decided not to pay for Roche Holding's drug Avastin to treat breast cancer after health advisers said it was not safe or clinically beneficial. Blue Shield of California with around 3.3 million members, said in a notice posted on its web site that the drug would no longer be covered as a treatment for metastatic breast cancer beginning October 17. It said exceptions may be considered on a case-by-case basis.
Because critical care nurses are often among those caring for patients during their final days, the American Association of Critical-Care Nurses joins national, state and community organizations in support of the third annual National Healthcare Decisions Day on Friday, April 16, 2010.
Scientists at Stanford University have identified a gene that may play a role in the development of type 1 diabetes, an autoimmune disease in which the immune system attacks the body's insulin-producing cells. Insulin, a hormone produced by cells of the pancreas, helps the body to absorb sugars found in food and to maintain blood sugar at appropriate levels.
› Verified 3 days ago
| Entity Name | Memorial Sloan Kettering Cancer Center At Basking Ridge New Jersey |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184637886 PECOS PAC ID: 0143229534 Enrollment ID: O20061213000044 |
News Archive
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that its collaborator Genentech, a member of the Roche Group, has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking sales and marketing approval for vismodegib to treat people with advanced basal cell carcinoma (BCC), which includes metastatic and locally advanced BCC for whom surgery is inappropriate.
How do viral pathogens succeed in penetrating human cells? Which cellular mechanisms do they use to multiply efficiently and, in doing so, how do they change the structure of their host cell? These questions are the focus of a pan-European research project called "Compact Cell-Imaging Device" (CoCID), in which Heidelberg scientists are playing a major role.
In a new development, health insurer Blue Shield of California has decided not to pay for Roche Holding's drug Avastin to treat breast cancer after health advisers said it was not safe or clinically beneficial. Blue Shield of California with around 3.3 million members, said in a notice posted on its web site that the drug would no longer be covered as a treatment for metastatic breast cancer beginning October 17. It said exceptions may be considered on a case-by-case basis.
Because critical care nurses are often among those caring for patients during their final days, the American Association of Critical-Care Nurses joins national, state and community organizations in support of the third annual National Healthcare Decisions Day on Friday, April 16, 2010.
Scientists at Stanford University have identified a gene that may play a role in the development of type 1 diabetes, an autoimmune disease in which the immune system attacks the body's insulin-producing cells. Insulin, a hormone produced by cells of the pancreas, helps the body to absorb sugars found in food and to maintain blood sugar at appropriate levels.
› Verified 3 days ago
| Entity Name | Msk Bergen |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558814657 PECOS PAC ID: 1456614114 Enrollment ID: O20180410002157 |
News Archive
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that its collaborator Genentech, a member of the Roche Group, has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking sales and marketing approval for vismodegib to treat people with advanced basal cell carcinoma (BCC), which includes metastatic and locally advanced BCC for whom surgery is inappropriate.
How do viral pathogens succeed in penetrating human cells? Which cellular mechanisms do they use to multiply efficiently and, in doing so, how do they change the structure of their host cell? These questions are the focus of a pan-European research project called "Compact Cell-Imaging Device" (CoCID), in which Heidelberg scientists are playing a major role.
In a new development, health insurer Blue Shield of California has decided not to pay for Roche Holding's drug Avastin to treat breast cancer after health advisers said it was not safe or clinically beneficial. Blue Shield of California with around 3.3 million members, said in a notice posted on its web site that the drug would no longer be covered as a treatment for metastatic breast cancer beginning October 17. It said exceptions may be considered on a case-by-case basis.
Because critical care nurses are often among those caring for patients during their final days, the American Association of Critical-Care Nurses joins national, state and community organizations in support of the third annual National Healthcare Decisions Day on Friday, April 16, 2010.
Scientists at Stanford University have identified a gene that may play a role in the development of type 1 diabetes, an autoimmune disease in which the immune system attacks the body's insulin-producing cells. Insulin, a hormone produced by cells of the pancreas, helps the body to absorb sugars found in food and to maintain blood sugar at appropriate levels.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ping Gu, MD 225 Summit Avenue, Montvale, NJ 07645 Ph: (201) 775-7183 | Ping Gu, MD 225 Summit Avenue, Montvale, NJ 07645 Ph: (201) 775-7183 |
News Archive
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that its collaborator Genentech, a member of the Roche Group, has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking sales and marketing approval for vismodegib to treat people with advanced basal cell carcinoma (BCC), which includes metastatic and locally advanced BCC for whom surgery is inappropriate.
How do viral pathogens succeed in penetrating human cells? Which cellular mechanisms do they use to multiply efficiently and, in doing so, how do they change the structure of their host cell? These questions are the focus of a pan-European research project called "Compact Cell-Imaging Device" (CoCID), in which Heidelberg scientists are playing a major role.
In a new development, health insurer Blue Shield of California has decided not to pay for Roche Holding's drug Avastin to treat breast cancer after health advisers said it was not safe or clinically beneficial. Blue Shield of California with around 3.3 million members, said in a notice posted on its web site that the drug would no longer be covered as a treatment for metastatic breast cancer beginning October 17. It said exceptions may be considered on a case-by-case basis.
Because critical care nurses are often among those caring for patients during their final days, the American Association of Critical-Care Nurses joins national, state and community organizations in support of the third annual National Healthcare Decisions Day on Friday, April 16, 2010.
Scientists at Stanford University have identified a gene that may play a role in the development of type 1 diabetes, an autoimmune disease in which the immune system attacks the body's insulin-producing cells. Insulin, a hormone produced by cells of the pancreas, helps the body to absorb sugars found in food and to maintain blood sugar at appropriate levels.
› Verified 3 days ago
Dr. Gabriela Wojnarska-alvarez, MD Internal Medicine Medicare: May Accept Medicare Assignments Practice Location: 221 W Grand Ave, Suite 105, Montvale, NJ 07645 Phone: 101-746-9333 Fax: 201-746-9335 | |
Dr. Elizabeth Ann Kulesza, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 7 Stem Brook Rd, Montvale, NJ 07645 Phone: 201-476-0196 | |
Dr. Sakina Firoz Dinani, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 305 W Grand Ave Ste 900, Montvale, NJ 07645 Phone: 201-677-8680 Fax: 888-425-6116 | |
Dr. Rebecca M Varghese, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 8 E Grand Ave, Montvale, NJ 07645 Phone: 201-775-1153 Fax: 845-675-5005 | |
Dr. Anupama Doraiswamy, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 225 Summit Ave, Montvale, NJ 07645 Phone: 201-775-7000 | |
Dr. Anuja Kriplani, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 225 Summit Ave, Montvale, NJ 07645 Phone: 201-775-7443 |